+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Loss of function of transient receptor potential vanilloid 1 (TRPV1) genetic variant is associated with lower risk of active childhood asthma



Loss of function of transient receptor potential vanilloid 1 (TRPV1) genetic variant is associated with lower risk of active childhood asthma



Journal of Biological Chemistry 285(36): 27532-5



Transient receptor potential cation channels of the vanilloid subfamily (TRPV) participate in the generation of Ca(2+) signals at different locations of the respiratory system, thereby controlling its correct functioning. TRPV1 expression and activity appear to be altered under pathophysiological conditions such as chronic cough and airway hypersensitivity, whereas TRPV4 single nucleotide polymorphisms (SNP) are associated with chronic obstructive pulmonary disease. However, to date, there is no information about the genetic impact of either TRPV1 or TRPV4 on asthma pathophysiology. We now report on the association of two functional SNPs, TRPV1-I585V and TRPV4-P19S, with childhood asthma. Both SNPs were genotyped in a population of 470 controls without respiratory symptoms and 301 asthmatics. Although none of the SNPs modified the risk of suffering from asthma, carriers of the TRPV1-I585V genetic variant showed a lower risk of current wheezing (odds ratio = 0.51; p = 0.01), a characteristic of active asthma, or cough (odds ratio = 0.57; p = 0.02). Functional analysis of TRPV1-I585V, using the Ca(2+)-sensitive dye fura-2 to measure intracellular [Ca(2+)] concentrations, revealed a decreased channel activity in response to two typical TRPV1 stimuli, heat and capsaicin. On the other hand, TRPV4-P19S, despite its loss-of-channel function, showed no significant association with asthma or the presence of wheezing. Our data suggest that genetically determined level of TRPV1 activity is relevant for asthma pathophysiology.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054180043

Download citation: RISBibTeXText

PMID: 20639579

DOI: 10.1074/jbc.c110.159491


Related references

Characterization of Transient Receptor Potential Vanilloid-1 (TRPV1) Variant Activation by Coal Fly Ash Particles and Associations with Altered Transient Receptor Potential Ankyrin-1 (TRPA1) Expression and Asthma. Journal of Biological Chemistry 291(48): 24866-24879, 2016

Association of the M3151 variant in the transient receptor potential vanilloid receptor-1 (TRPV1) gene with type 1 diabetes in an Ashkenazi Jewish population. Israel Medical Association Journal 15(9): 477-480, 2014

Novel Radiolabeled Vanilloid with Enhanced Specificity for Human Transient Receptor Potential Vanilloid 1 (TRPV1). Journal of Medicinal Chemistry 60(19): 8246-8252, 2017

Transient receptor potential vanilloid 2 (TRPV2), a potential novel biomarker in childhood asthma. Journal of Asthma 50(2): 209-214, 2013

Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain. Neuroscience 193: 440-451, 2012

Vascular Expression of Transient Receptor Potential Vanilloid 1 (TRPV1). Journal of Histochemistry and Cytochemistry 63(6): 449-453, 2015

Transient receptor potential vanilloid 1 (TRPV1) channels in cultured. 2008

Transient receptor potential vanilloid 1 (TRPV1), TRPV4, and the kidney. Acta Physiologica 207(3): 546-564, 2013

Activation of transient receptor potential vanilloid 1 (TRPV1) by resiniferatoxin. Journal of Physiology 567(Pt 3): 771-786, 2005

Xenon reduces activation of transient receptor potential vanilloid type 1 (TRPV1) in rat dorsal root ganglion cells and in human TRPV1-expressing HEK293 cells. Life Sciences 88(3-4): 141-149, 2011

Cloning and functional characterization of dog transient receptor potential vanilloid receptor-1 (TRPV1). European Journal of Pharmacology 513(1-2): 57-66, 2005

β-Arrestin-2 desensitizes the transient receptor potential vanilloid 1 (TRPV1) channel. Journal of Biological Chemistry 287(44): 37552-37563, 2013

[Pp.16.03] Is Transient Receptor Potential Vanilloid Type 1 (Trpv1) A New Target For Cardioprotection?. Journal of Hypertension 34: e212-e213, 2016

Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists. Journal of Medicinal Chemistry 53(8): 3330-3348, 2010

Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel. Pain 110(3): 616-627, 2004